5-(3,4-dihydroxybenzyl)thiazolidine-2,4-dione | 79525-05-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 5-(3,4-dihydroxybenzyl)thiazolidine-2,4-dione
• 英文别名: 5-[(3,4-dihydroxyphenyl)methyl]-1,3-thiazolidine-2,4-dione
• CAS: 79525-05-6
• 化学式: C₁₀H₉NO₄S
• 分子量: 239.252
• InChiKey: BDVGWQVSMPATBP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  112
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  5-(3,4-dihydroxybenzyl)thiazolidine-2,4-dione 、 乙酸酐 在 吡啶 作用下， 以60.1%的产率得到5-(3,4-diacetoxybenzyl)thiazolidine-2,4-dione
  参考文献：
  名称：

  Antiulcer activity of 5-benzylthiazolidine-2,4-dione derivatives.

  摘要：

  制备了5-苄基-噻唑烷-2,4-二酮衍生物，并通过结扎大鼠幽门和水浸应激大鼠模型进行了抗分泌和抗溃疡活性的检验。其中一些化合物，尤其是5-(2, 4, 5-三丙氧基苄基)噻唑烷-2, 4-二酮（4）和5-(2, 4-二甲氧基苄基)噻唑烷-2, 4-二酮（23），表现出显著的药理活性。结构-活性关系在此进行了讨论。

  DOI：

  10.1248/cpb.31.560
• 作为产物：
  描述：

  5-(3-Ethoxy-4-hydroxy-benzyl)-thiazolidine-2,4-dione 在 三溴化硼 作用下， 以 氯仿 为溶剂， 以25.5%的产率得到5-(3,4-dihydroxybenzyl)thiazolidine-2,4-dione
  参考文献：
  名称：

  Antiulcer activity of 5-benzylthiazolidine-2,4-dione derivatives.

  摘要：

  制备了5-苄基-噻唑烷-2,4-二酮衍生物，并通过结扎大鼠幽门和水浸应激大鼠模型进行了抗分泌和抗溃疡活性的检验。其中一些化合物，尤其是5-(2, 4, 5-三丙氧基苄基)噻唑烷-2, 4-二酮（4）和5-(2, 4-二甲氧基苄基)噻唑烷-2, 4-二酮（23），表现出显著的药理活性。结构-活性关系在此进行了讨论。

  DOI：

  10.1248/cpb.31.560

文献信息

• SOHDA, TAKASHI;MIZUNO, KATSUTOSHI;HIRATA, TAKEO;MAKI, YOSHITAKA;KAWAMATSU+, CHEM. AND PHARM. BULL., 1983, 31, N 2, 560-569
  作者：SOHDA, TAKASHI、MIZUNO, KATSUTOSHI、HIRATA, TAKEO、MAKI, YOSHITAKA、KAWAMATSU+

  DOI：——

  日期：——
• US4376777A
  申请人：——

  公开号：US4376777A

  公开（公告）日：1983-03-15
• [EN] THIAZOLIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS<br/>[FR] DERIVES DE THIAZOLIDINE UTILES POUR LE TRAITEMENT ET LA PREVENTION DE TROUBLES METABOLIQUES DES OS
  申请人：ROCHE DIAGNOSTICS GMBH

  公开号：WO2000018746A1

  公开（公告）日：2000-04-06

  The object of the present invention are compounds of general formula (I), in which: m signifies a number between 0-8; q signifies a number between 0-8; A signifies a single or double bond; R1 signifies hydrogen or, when X and Z are oxygen, also -(CH2)-COR4 with a =0-6; R2, R3 signify hydrogen or lower alkyl, whereby R2 and R3 can be the same or different and, when m signifies 2-8, R2 and R3 in the group CR2=CR3 can have various significances within the following sequence; R4 signifies hydroxyl, lower alkoxy or the NR1R2 residue, whereby R1 and R2 can be the same or different; X signifies oxygen or imino; Z signifies oxygen, sulfur or imino; W signifies an optionally mono- or polysubstituted saturated or unsaturated mono-, bi- or tricycle which can contain one or more hetero atoms, as well as their physiologically compatible salts, esters, optically active forms, racemates, tautomers, as well as derivatives which can be metabolized in vivo to compounds of general formula (I), as well as the use of these compounds for the production of medicaments for the prophylaxis or therapy of metabolic bone disorders.
• Antiulcer activity of 5-benzylthiazolidine-2,4-dione derivatives.
  作者：TAKASHI SOHDA、KATSUTOSHI MIZUNO、TAKEO HIRATA、YOSHITAKA MAKI、YUTAKA KAWAMATSU

  DOI：10.1248/cpb.31.560

  日期：——

  5-Benzylthiazolidine-2, 4-dione derivatives were prepared and examined for antisecretory and antiulcer activities using pylorus-ligated rats and water-immersion stress rats. Some of these compounds, in particular, 5-(2, 4, 5-tripropoxybenzyl) thiazolidine-2, 4-dione (4) and 5-(2, 4-dimethoxybenzyl) thiazolidine-2, 4-dione (23), exhibited pronounced pharmacological activities. Structure-activity relationships are discussed.

  制备了5-苄基-噻唑烷-2,4-二酮衍生物，并通过结扎大鼠幽门和水浸应激大鼠模型进行了抗分泌和抗溃疡活性的检验。其中一些化合物，尤其是5-(2, 4, 5-三丙氧基苄基)噻唑烷-2, 4-二酮（4）和5-(2, 4-二甲氧基苄基)噻唑烷-2, 4-二酮（23），表现出显著的药理活性。结构-活性关系在此进行了讨论。